| Pharmaceutical Information |
| Drug Name |
Ambenonium chloride |
| Drug ID |
BADD_D00099 |
| Description |
Ambenonium is a cholinesterase inhibitor. It is used in the management of myasthenia gravis. |
| Indications and Usage |
Ambenonium is used to treat muscle weakness due to muscle disease (myasthenia gravis). |
| Marketing Status |
Discontinued |
| ATC Code |
N07AA30 |
| DrugBank ID |
DB01122
|
| KEGG ID |
D01001
|
| MeSH ID |
D000549
|
| PubChem ID |
8288
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
65392-1002 |
| Synonyms |
Ambenonium Chloride | Chloride, Ambenonium | Mytelase |
|
| Chemical Information |
| Molecular Formula |
C28H42Cl4N4O2 |
| CAS Registry Number |
115-79-7 |
| SMILES |
CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC2=CC=CC=C2Cl.[Cl-].[Cl-] |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
